Role of shear-stress-induced VEGF expression in endothelial cell survival

Journal of Cell Science

Volumn 125, Issue 4, 2012, Pages 831-843

  dela Paz, Nathaniel G ^a   Walshe, Tony E ^a   Leach, Lyndsay L ^a   Saint Geniez, Magali ^a   D'Amore, Patricia A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Endothelial cells; KLF2; Shear stress; VEGF; VEGFR2

Indexed keywords

KRUPPEL LIKE FACTOR 2; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 2;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEAR STRESS; UMBILICAL VEIN; UPREGULATION;

ANIMALS; ARTERIES; CAPILLARIES; CELL SURVIVAL; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; STRESS, MECHANICAL; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VEINS;

EID: 84861207235     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.084301     Document Type: Article

References (75)

1. Abumiya, T., Sasaguri, T., Taba, Y., Miwa, Y. and Miyagi, M. (2002). Shear stress induces expression of vascular endothelial growth factor receptor Flk-1/KDR through the CT-rich Sp1 binding site. Arterioscler. Thromb. Vasc. Biol. 22, 907-913.
2. Achen, M. G., Jeltsch, M., Kukk, E., Mäkinen, T., Vitali, A., Wilks, A. F., Alitalo, K. and Stacker, S. A. (1998). Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA 95, 548-553.
3. Atkins, G. B. and Jain, M. K. (2007). Role of Kruppel-like transcription factors in endothelial biology. Circ. Res. 100, 1686-1695.
4. Baffert F., Le, T., Sennino, B., Thurston G., Kuo, C. J., Hu-Lowe, D. and McDonald, D. M. (2006). Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am. J. Physiol. Heart Circ. Physiol. 290, H547-H559.
5. Ballermann, B. J., Dardik, A., Eng, E. and Liu, A. (1998). Shear stress and the endothelium. Kidney Int. Suppl. 67, S100-S108.
6. Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F. and Senger, D. R. (1992). Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3, 211-220.
7. Boguslawski, G., McGlynn, P. W., Harvey, K. A. and Kovala, A. T. (2004). SU1498, an inhibitor of vascular endothelial growth factor receptor 2, causes accumulation of phosphorylated ERK kinases and inhibits their activity in vivo and in vitro. J. Biol. Chem. 279, 5716-5724.
8. Brogi, E., Wu, T., Namiki, A. and Isner, J. M. (1994). Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90, 649-652.
9. Brown, L. F., Yeo, K. T., Berse, B., Yeo, T. K., Senger, D. R., Dvorak, H. F. and van de Water, L. (1992a). Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J. Exp. Med. 176, 1375-1379.
10. Brown, L. F., Berse, B., Tognazzi, K., Manseau, E. J., Van de Water, L., Senger, D. R., Dvorak, H. F. and Rosen, S. (1992b). Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int. 42, 1457-1461.
11. Bryan, B. A., Walshe, T. E., Mitchell, D. C., Havumaki, J. S., Saint-Geniez, M., Maharaj, A. S., Maldonado, A. E. and D'Amore, P. A. (2008). Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation. Mol. Biol. Cell 19, 994-1006.
12. Clauss, M., Weich, H., Breier, G., Knies, U., Röckl, W., Waltenberger, J. and Risau, W. (1996). The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271, 17629-17634.
13. D'Amore, P. (2007). Vascular endothelial cell growth factor-A: Not just for endothelial cells anymore. Am. J. Pathol. 171, 14-18.
14. Dardik, A., Chen, L., Frattini, J., Asada, H., Aziz, F., Kudo, F. A. and Sumpio, B. E. (2005). Differential effects of orbital and laminar shear stress on endothelial cells. J. Vasc. Surg. 41, 869-880.
15. Dekker, R. J., van Soest, S., Fontijn, R. D., Salamanca, S., de Groot, P. G., VanBavel, E., Pannekoek, H. and Horrevoets, A. J. (2002). Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel-like factor (KLF2). Blood 100, 1689-1698.
16. Dekker, R. J., van Thienen, J. V., Rohlena, J., de Jager, S. C., Elderkamp, Y. W., Seppen, J., de Vries, C. J., Biessen, E. A., van Berkel, T. J., Pannekoek, H. et al. (2005). Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. Am. J. Pathol. 167, 609-618.
17. Dekker, R. J., Boon, R. A., Rondaij, M. G., Kragt, A., Volger, O. L., Elderkamp, Y. W., Meijers, J. C., Voorberg, J., Pannekoek, H. and Horrevoets, A. J. (2006). KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood 107, 4354-4363.
18. dela Paz, N. G. and D'Amore, P. A. (2008). Arterial versus venous endothelial cells. Cell Tissue Res. 335, 5-16.
19. Dimmeler, S., Haendeler, J., Rippmann, V., Nehls, M. and Zeiher, A. M. (1996). Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett. 399, 71-74.
20. Ferrara, N. and Henzel, W. J. (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161, 851-858.
21. Ferrara, N., Gerber, H. P. and LeCouter, J. (2003). The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
22. Frank, S., Hübner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G. and Werner, S. (1995). Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J. Biol. Chem. 270, 12607-12613.
23. Goettsch, W., Gryczka, C., Korff, T., Ernst, E., Goettsch, C., Seebach, J., Schnittler, H. J., Augustin, H. G. and Morawietz, H. (2008). Flow-dependent regulation of angiopoietin-2. J. Cell. Physiol. 214, 491-503.
24. Grazia Lampugnani, M., Zanetti, A., Corada, M., Takahashi, T., Balconi, G., Breviario, F., Orsenigo, F., Cattelino, A., Kemler, R., Daniel, T. O. et al. (2003). Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J. Cell. Biol. 161, 793-804.
25. Gruden, G., Thomas, S., Burt, D., Lane, S., Chusney, G., Sacks, S. and Viberti, G. (1997). Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction. Proc. Natl. Acad. Sci. USA 94, 12112-12116.
26. Hood, J. D., Meininger, C. J., Ziche, M. and Granger, H. J. (1998). VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am. J. Physiol. 274, H1054-H1058.
27. Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B. and Leung, D. W. (1991). The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5, 1806-1814.
28. Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J. and Ferrara, N. (1992). Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267, 26031-26037.
29. Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E. et al. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 350, 2335-2342.
30. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N. and Alitalo, K. (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 290-298.
31. Kamba, T., Tam, B. Y. Y., Hashizume H., Haskell A., Sennino, B., Mancuso, M. R., Norberg, S. M., O'Brien, S. M., Davis, R. B., Gowen, L. C. et al. (2006). VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am. J. Physiol. Heart Circ. Physiol. 290, H560-H576.
32. Kuhn, A., Brachtendorf, G., Kurth, F., Sonntag, M., Samulowitz, U., Metze, D. and Vestweber, D. (2002). Expression of endomucin, a novel endothelial sialomucin, in normal and diseased human skin. J. Invest. Dermatol. 119, 1388-1393.
33. Kuo, C. T., Veselits, M. L., Barton, K. P., Lu, M. M., Clendenin, C. and Leiden, J. M. (1997). The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev. 11, 2996-3006.
34. Lee, S., Chen, T. T., Barber, C. L., Jordan, M. C., Murdock, J., Desai, S., Ferrara, N., Nagy, A., Roos, K. P. and Iruela-Arispe, M. L. (2007). Autocrine VEGF signaling is required for vascular homeostasis. Cell 130, 691-703.
35. Ley, K., Lundgren, E., Berger, E. and Arfors, K. E. (1989). Shear-dependent inhibition of granulocyte adhesion to cultured endothelium by dextran sulfate. Blood 73, 1324-1330.
36. Li, M., Scott, D. E., Shandas, R., Stenmark, K. R. and Tan, W. (2009). High pulsatility flow induces adhesion molecule and cytokine mRNA expression in distal pulmonary artery endothelial cells. Ann. Biomed. Eng. 37, 1082-1092.
37. Lin, Z., Kumar, A., SenBanerjee, S., Staniszewski, K., Parmar, K., Vaughan, D. E., Gimbrone, M. A., Jr, Balasubramanian, V., Garcia-Cardena, G. and Jain, M. K. (2005). Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ. Res. 96, e48-e57.
38. Lipowsky, H. H., Kovalcheck, S. and Zweifach, B. W. (1978). The distribution of blood rheological parameters in the microvasculature of cat mesentery. Circ. Res. 43, 738-749.
39. Loureiro, R. and D'Amore, P. (2005). Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine Growth Factor Rev. 16, 77-89.
40. Maharaj, A. S. and D'Amore, P. A. (2007). Roles for VEGF in the adult. Microvasc. Res. 74, 100-113.
41. Maharaj, A. S., Saint-Geniez, M., Maldonado, A. E. and D'Amore, P. A. (2006). Vascular endothelial growth factor localization in the adult. Am. J. Pathol. 168,639-648.
42. Masumura, T., Yamamoto, K., Shimizu, N., Obi, S. and Ando, J. (2009). Shear stress increases expression of the arterial endothelial marker EphrinB2 in murine ES cells via the VEGF-Notch signaling pathways. Arterioscler. Thromb. Vasc. Biol. 29, 2125-2131.
43. Mata-Greenwood, E., Grobe, A., Kumar, S., Noskina, Y. and Black, S. M. (2005). Cyclic stretch increases VEGF expression in pulmonary arterial smooth muscle cells via TGF-beta1 and reactive oxygen species: a requirement for NAD(P)H oxidase. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L288-L289.
44. Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P., Risau, W. and Ullrich, A. (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.
45. Miquerol, L., Gertsenstein, M., Harpal, K., Rossant, J. and Nagy, A. (1999). Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. Dev. Biol. 212, 307-322.
46. Motokawa, M., Kaku, M., Tohma, Y., Kawata, T., Fujita, T., Kohno, S., Tsutsui, K., Ohtani, J., Tenjo, K., Shigekawa, M. et al. (2005). Effects of cyclic tensile forces on the expression of vascular endothelial growth factor (VEGF) and macrophage-colony-stimulating factor (M-CSF) in murine osteoblastic MC3T3-E1 cells. J. Dent. Res. 84, 422-427.
47. Muratore, C. S., Nguyen, H. T., Ziegler, M. M. and Wilson, J. M. (2000). Stretch-induced upregulation of VEGF gene expression in murine pulmonary culture: a role for angiogenesis in lung development. J. Pediatr. Surg. 35, 906-912; discussion 912-903.
48. Ng, Y. S., Rohan, R., Sunday, M. E., Demello, D. E. and D'Amore, P. A. (2001). Differential expression of VEGF isoforms in mouse during development and in the adult. Dev. Dyn. 220, 112-121.
49. Otani, N., Minami, S., Yamoto, M., Shikone, T., Otani, H., Nishiyama, R., Otani, T. and Nakano, R. (1999). The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy. J. Clin. Endocrinol. Metab. 84, 3845-3851.
50. Papaioannou, T. G. and Stefanadis, C. (2005). Vascular wall shear stress: basic principles and methods. Hellenic J. Cardiol. 46, 9-15.
51. Parmar, K. M., Larman, H. B., Dai, G., Zhang, Y., Wang, E. T., Moorthy, S. N., Kratz, J. R., Lin, Z., Jain, M. K., Gimbrone, M. A., Jr. et al. (2006). Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J. Clin. Invest. 116, 49-58.
52. Quinn, T. P., Schlueter, M., Soifer, S. J. and Gutierrez, J. A. (2002). Cyclic mechanical stretch induces VEGF and FGF-2 expression in pulmonary vascular smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, L897-L903.
53. Ramsauer, M. and D'Amore, P. A. (2007). Contextual role for angiopoietins and TGFbeta1 in blood vessel stabilization. J. Cell. Sci. 120, 1810-1817.
54. Saint-Geniez, M., Maldonado, A. E. and D'Amore, P. A. (2006). VEGF expression and receptor activation in the choroid during development and in the adult. Invest. Ophthalmol. Vis. Sci. 47, 3135-3142.
55. Saint-Geniez, M., Maharaj, A., Walshe, T., Tucker, B., Sekiyama, E., Kurihara, T., Darland, D., Young, M., D'Amore, P. and Chan-Ling, T. (2008). Endogenous VEGF is required for visual function: Evidence for a survival role on Müller cells and photoreceptors. PLoS ONE 3, e3554.
56. Samulowitz, U., Kuhn, A., Brachtendorf, G., Nawroth, R., Braun, A., Bankfalvi, A., Böcker, W. and Vestweber, D. (2002). Human endomucin: distribution pattern, expression on high endothelial venules, and decoration with the MECA-79 epitope. Am. J. Pathol. 160, 1669-1681.
57. Seko, Y., Seko, Y., Takahashi, N., Shibuya, M. and Yazaki, Y. (1999a). Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochem. Biophys. Res. Commun. 254, 462-465.
58. Seko, Y., Seko, Y., Fujikura, H., Pang, J., Tokoro, T. and Shimokawa, H. (1999b). Induction of vascular endothelial growth factor after application of mechanical stress to retinal pigment epithelium of the rat in vitro. Invest. Ophthalmol. Vis. Sci. 40, 3287-3291.
59. SenBanerjee, S., Lin, Z., Atkins, G. B., Greif, D. M., Rao, R. M., Kumar, A., Feinberg, M. W., Chen, Z., Simon, D. I., Luscinskas, F. W. et al. (2004). KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J. Exp. Med. 199, 1305-1315.
60. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S. and Dvorak, H. F. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985.
61. Shay-Salit, A., Shushy, M., Wolfovitz, E., Yahav, H., Breviario, F., Dejana, E. and Resnick, N. (2002). VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells. Proc. Natl. Acad. Sci. USA 99, 9462-9467.
62. Shweiki, D., Itin, A., Soffer, D. and Keshet, E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-845.
63. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G. and Klagsbrun, M. (1998). Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745.
64. Strawn, L. M., McMahon, G., App, H., Schreck, R., Kuchler, W. R., Longhi, M. P., Hui, T. H., Tang, C., Levitzki, A., Gazit, A. et al. (1996). Flk-1 as a target for tumor growth inhibition. Cancer Res. 56, 3540-3545.
65. Suzuki, T., Aizawa, K., Matsumura, T. and Nagai, R. (2005). Vascular implications of the Kruppel-like family of transcription factors. Arterioscler. Thromb. Vasc. Biol. 25, 1135-1141.
66. Suzuma, I., Hata, Y., Clermont, A., Pokras, F., Rook, S. L., Suzuma, K., Feener, E. P. and Aiello, L. P. (2001). Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes 50, 444-454.
67. Thi, M. M., Iacobas, D. A., Iacobas, S. and Spray, D. C. (2007). Fluid shear stress upregulates vascular endothelial growth factor gene expression in osteoblasts. Ann. N.Y. Acad. Sci. 1117, 73-81.
68. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C. and Abraham, J. A. (1991). The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11947-11954.
69. Urbich, C., Stein, M., Reisinger, K., Kaufmann, R., Dimmeler, S. and Gille, J. (2003). Fluid shear stress-induced transcriptional activation of the vascular endothelial growth factor receptor-2 gene requires Sp1-dependent DNA binding. FEBS Lett. 535, 87-93.
70. Walshe, T., Saint-Geniez, M., Maharaj, A., Sekiyama, E., Maldonado, A., D'Amore, P. and Eickelberg, O. (2009). TGF-ββ is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS ONE 4, e5149.
71. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. and Heldin, C. H. (1994). Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269, 26988-26995.
72. Wang, Y., Miao, H., Li, S., Chen, K. D., Li, Y. S., Yuan, S., Shyy, J. Y. and Chien, S. (2002). Interplay between integrins and FLK-1 in shear stress-induced signaling. Am. J. Physiol. Cell Physiol. 283, C1540-C1547.
73. Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V. et al. (2004). Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat. Med. 10, 145-147.
74. Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X. and Rosenberg, S. A. (2003). A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N. Engl. J. Med. 349, 427-434.
75. Zheng, W., Seftor, E. A., Meininger, C. J., Hendrix, M. J. and Tomanek, R. J. (2001). Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGF-beta. Am. J. Physiol. Heart Circ. Physiol. 280, H909-H917.